Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC

Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Treatment decision guided by CTC count may improve long-term outcomes for mBC

The future of precision oncology

The concept of pan-tumour therapeutics

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs.

Monitoring and evaluation as a tool for quality improvement in cancer screening

Cloud software for helping build quality assurance in radiotherapy

Is Latin America ready to overcome the challenges of implementing Precision Medicine?